EX-32.1 5 ex32-1.htm EXHIBIT 32.1 ex31-1.htm

Exhibit 32.1

 

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

I, David B. Kaysen, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1)

  

the Annual Report on Form 10-K of Sun BioPharma, Inc. for the year ended December 31, 2015 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

     

(2)

  

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Sun BioPharma, Inc.

 

Dated: March 8, 2016

 

 

 

/s/ David B. Kaysen

 

David B. Kaysen

 

President and Chief Executive Officer

 

(Principal Executive Officer)